| 0 (0%) | 09-27 13:02 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.82 | 1-year : | 1.03 |
| Resists | First : | 0.7 | Second : | 0.88 |
| Pivot price | 0.54 |
|||
| Supports | First : | 0.4 | Second : | 0.34 |
| MAs | MA(5) : | 0.46 |
MA(20) : | 0.58 |
| MA(100) : | 1.23 |
MA(250) : | 1.63 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2  |
| %K %D | K(14,3) : | 8 |
D(3) : | 14 |
| RSI | RSI(14): 34.9 |
|||
| 52-week | High : | 2.86 | Low : | 0.37 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ NBRV ] has closed above bottom band by 16.1%. Bollinger Bands are 7.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.55 - 0.55 | 0.55 - 0.56 |
| Low: | 0.4 - 0.41 | 0.41 - 0.41 |
| Close: | 0.41 - 0.41 | 0.41 - 0.41 |
Fri, 19 Jul 2024
CWU electioneering for Labour: delivering the Starmer government’s pro-business agenda against postal workers - World Socialist Web Site
Fri, 16 Sep 2022
Rigetti (RGTI) Stock Pops on New Quantum Computing Partners - InvestorPlace
Fri, 16 Sep 2022
What Is Going on With Nabriva Therapeutics (NBRV) Stock Today? - InvestorPlace
Wed, 17 Jun 2020
FDA expects to rule on King of Prussia biopharm firm's new drug candidate - The Business Journals
Mon, 19 Aug 2019
Nabriva Therapeutics Receives U.S. FDA Approval of Xenleta™ - GlobeNewswire
Tue, 30 Apr 2019
Nabriva Therapeutics Receives Complete Response Letter from - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | -3.2 |
| Sales Per Share | 11.4 |
| EBITDA (p.s.) | -14.65 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0.03 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|